Apellis Pharmaceuticals Inc. (APLS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Apellis Pharmaceuticals I...

    NASDAQ: APLS · Real-Time Price · USD
    23.80
    0.69 (2.99%)
    At close: Oct 03, 2025, 3:59 PM
    23.78
    -0.08%
    After-hours: Oct 03, 2025, 07:17 PM EDT

    Apellis Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -197.88M -528.63M -652.17M -746.35M
    Depreciation & Amortization
    		 1.8M 1.7M 1.49M 1.49M
    Stock-Based Compensation
    		 114.13M 105.94M 91.08M 70.67M
    Other Working Capital
    		 49.79M -200.34M 32.63M -77.59M
    Other Non-Cash Items
    		 12.44M 26.41M 61.55M 6.33M
    Deferred Income Tax
    		 n/a n/a n/a 198.26M
    Change in Working Capital
    		 -18.36M -200.17M -15.7M -93.52M
    Operating Cash Flow
    		 -87.87M -594.74M -513.75M -563.13M
    Capital Expenditures
    		 -403K -773K -1.52M -1.1M
    Cash Acquisitions
    		 n/a n/a -61.42M -248.72M
    Purchase of Investments
    		 n/a n/a -331.86M -171.28M
    Sales Maturities Of Investments
    		 n/a n/a 393.28M 420M
    Other Investing Acitivies
    		 n/a 99K 61.42M 248.72M
    Investing Cash Flow
    		 -403K -674K 59.89M 247.62M
    Debt Repayment
    		 365.45M n/a n/a n/a
    Common Stock Repurchased
    		 4.51M n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -216.21M 10.11M -14.46M 11.87M
    Financial Cash Flow
    		 149.24M 394.5M 365.66M 392.24M
    Net Cash Flow
    		 60.31M -200.78M -88.68M 74.71M
    Free Cash Flow
    		 -88.27M -595.51M -515.27M -564.23M

    Add to Watchlist